Evidence map›Paper›PMID 32821467›Full record

ArticleMedeniyet medical journal2019

Heterozygous Beta Chain Variant Hemoglobin Pusan: A Rare Case Report in Turkish Population.

Durmus Ayan, Ozgur Kirbiyik, Berk Ozyilmaz

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Medeniyet medical journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 74% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Durmus AyanAmasya University, Sabuncuoğlu Şerefeddin Training and Research Hospital, Department of Medical Biochemistry, Amasya, Turkey.ORCID 0000-0003-2615-8474
Ozgur KirbiyikIzmir Tepecik Training and Research Hospital, Department of Medical Genetic, Izmir, Turkey.ORCID 0000-0003-1333-2007
Berk OzyilmazIzmir Tepecik Training and Research Hospital, Department of Medical Genetic, Izmir, Turkey.ORCID 0000-0003-2654-3698
Izmir University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The case, detected during routine thalassemia (hemoglobin variant) screening, was a 25-year-old male patient of Turkish origin. Physical examination revealed no abnormal findings. Laboratory findings did not reveal any signs of anemia (iron deficiency, B12 deficiency, etc.). However, when the hemoglobin variant report was being evaluated, it was found that besides the normal hemoglobin peaks, there was another peak that had not been defined before. The sample was sent to genetic analysis for verification with the suspicion of an unknown hemoglobin variant. According to the genetic analysis, the unknown hemoglobin variant was found to be Hemoglobin Pusan (Hb Pusan). The aim of this study is to give information about a hemoglobin variant which is rarely seen in Turkish population and to raise awareness about this hemoglobin variant. In addition, clinical and hematological findings of this disease are discussed in the case report.

Indexed as

hemoglobin disordershemoglobin PusanThalassemiathalassemia-like diseases

Identifiers

PMID32821467
PMCPMC7433718
OpenAlexW2999347365

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.